Last but not least…Nimotuzumab in KRAS wild type
#PancreaticCancer
presented at
#ASCO2022
Nimotuzumab is an anti-EGFR monoclonal antibody.
@OncoAlert
🚨
#pancsm
💜
#PrecisionMedicine
2
21
52
Replies
@BenWestphalen
@OncoAlert
CIMAher (nimotizumab) is a humanized antibody that recognizes the
High affinity Epidermal Growth Factor receptor.
It was obtained by inserting the hypervariable regions or
determinants of murine antibody complementarity
ior egf/r3 in human immunoglobulin frameworks,
1
0
0